| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jul 10, 2018 | Jul 12, 2018 | Clancy Paul J EVP CFO | Sell | Alexion Pharmaceuticals, Inc. | ALXN | $131.11 | $687,148 | -5.32% |
| Feb 08, 2018 | Feb 09, 2018 | Clancy Paul J EVP CFO | Sell | Alexion Pharmaceuticals Inc | ALXN | $116.31 | $707,048 | -6.39% |
| Apr 25, 2017 | Apr 27, 2017 | Clancy Paul J EVP CFO | Sell | Biogen Inc. | BIIB | $290 | $3M | -47.78% |
| Mar 13, 2017 | Mar 14, 2017 | Clancy Paul J EVP CFO | Sell | Biogen Inc. | BIIB | $291.55 | $3M | -32.33% |
| Sep 18, 2013 | Sep 19, 2013 | Clancy Paul J EVP CFO | Sell | Biogen Idec Inc. | BIIB | $245 | $7M | -79.08% |
| Sep 16, 2013 | Sep 18, 2013 | Clancy Paul J EVP CFO | Sell | Biogen Idec Inc. | BIIB | $238.27 | $24M | -93.32% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.